Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study. (2020)
Attributed to:
MICA: Targeting neuro-inflammation in Schizophrenia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41386-019-0541-2
PubMed Identifier: 31618752
Publication URI: http://europepmc.org/abstract/MED/31618752
Type: Journal Article/Review
Volume: 45
Parent Publication: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Issue: 4
ISSN: 0893-133X